HGK displayed cytotoxic effects against NSCLC cells harboring constitutive activating EGFR mutations, including TKI-resistant H1975 and TKI-sensitive PC9 cells (Figure 1). The gene discussed is MAP4K4; the disease is non-small cell lung carcinoma.